Literature DB >> 6834478

Transformation of rat cells by cyt mutants of adenovirus type 12 and mutants of adenovirus type 5.

I Mak, S Mak.   

Abstract

Several mutants with much reduced oncogenicity (spontaneous mutants H12 cyt 52 and H12 cyt 70 and UV-induced mutants H12 cyt 61, H12 cyt 62, and H12 cyt 68) of the highly oncogenic adenovirus type 12 (Ad12) were studied for their ability to transform primary baby rat kidney cells. Four of the mutants showed much reduced capacity to transform cells in vitro, while H12 cyt 61 transformed cells as efficiently as the wild-type virus. Viral gene expression in several cell lines established from cultures infected by cyt mutants was studied, and it was found that viral sequences belonging to the left 16% of Ad12 were always transcribed. These results suggest that the function of the transformed state is not defective in the cyt mutants studied. Heterotypic complementation studies showed that the defect(s) in a cyt mutant can be corrected by an Ad7 function. Ad5 dl 313, with a deletion between 3.5 and 10.5 map units, transformed rat cells only at high multiplicity. These results suggest that the region E1B of adenoviruses may be required for efficient transformation of rat cells.

Entities:  

Mesh:

Year:  1983        PMID: 6834478      PMCID: PMC256519     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography.

Authors:  R A Laskey; A D Mills
Journal:  Eur J Biochem       Date:  1975-08-15

2.  Studies on in vitro transformation by DNA and DNA fragments of human adenoviruses and simian virus 40.

Authors:  F L Graham; P J Abrahams; C Mulder; H L Heijneker; S O Warnaar; F A De Vries; W Fiers; A J Van Der Eb
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

3.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

4.  Transcription of the genome of adenovirus type 12. III. Maps of stable RNA from productively infected human cells and abortively infected and transformed hamster cells.

Authors:  J Ortin; K H Scheidtmann; R Greenberg; M Westphal; W Doerfler
Journal:  J Virol       Date:  1976-11       Impact factor: 5.103

5.  Comparative studies on functions of human adenovirus type 12 and its low oncogenic mutant virions.

Authors:  H Ezoe; S Mak
Journal:  J Virol       Date:  1974-10       Impact factor: 5.103

6.  Genetic studies with tumorigenic adenoviruses. 3. Recombination in adenovirus type 12.

Authors:  N Takemori
Journal:  Virology       Date:  1972-01       Impact factor: 3.616

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Genetic studies with tumorigenic adenoviruses. II. Heterogeneity of cyt mutants of adenovirus type 12.

Authors:  N Takemori; J L Riggs; C D Aldrich
Journal:  Virology       Date:  1969-05       Impact factor: 3.616

9.  Genetic studies with tumorigenic adenoviruses. I. Isolation of cytocidal (cyt) mutants of adenovirus type 12.

Authors:  N Takemori; J L Riggs; C Aldrich
Journal:  Virology       Date:  1968-12       Impact factor: 3.616

10.  Host-range mutants of adenovirus type 5 defective for growth in HeLa cells.

Authors:  T Harrison; F Graham; J Williams
Journal:  Virology       Date:  1977-03       Impact factor: 3.616

View more
  12 in total

1.  Overexpression of the E1B 55-kilodalton (482R) protein of human adenovirus type 12 appears to permit efficient transformation of primary baby rat kidney cells in the absence of the E1B 19-kilodalton protein.

Authors:  S Zhang; S Mak; P E Branton
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Adenovirus type 12 E1B 19-kilodalton protein is not required for oncogenic transformation in rats.

Authors:  C Edbauer; C Lamberti; J Tong; J Williams
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

Review 3.  The structure and functions of the adenovirus early region 1 proteins.

Authors:  R J Grand
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

4.  Independent mutations in Ad2ts111 cause degradation of cellular DNA and defective viral DNA replication.

Authors:  B W Stillman; E White; T Grodzicker
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

5.  An adenovirus 2-coded tumor antigen located on the endoplasmic reticulum and nuclear envelope is required for growth of transformed cells in Ca2+-deficient media.

Authors:  T Subramanian; M Kuppuswamy; G Chinnadurai
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

6.  Tumorigenicity of adenovirus-transformed rodent cells is influenced by at least two regions of adenovirus type 12 early region 1A.

Authors:  T Jelinek; D S Pereira; F L Graham
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

7.  The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells.

Authors:  L R Gooding; L Aquino; P J Duerksen-Hughes; D Day; T M Horton; S P Yei; W S Wold
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

8.  cyt gene of adenoviruses 2 and 5 is an oncogene for transforming function in early region E1B and encodes the E1B 19,000-molecular-weight polypeptide.

Authors:  N Takemori; C Cladaras; B Bhat; A J Conley; W S Wold
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

9.  Mutations in the gene encoding the adenovirus early region 1B 19,000-molecular-weight tumor antigen cause the degradation of chromosomal DNA.

Authors:  E White; T Grodzicker; B W Stillman
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

10.  Deletion of the gene encoding the adenovirus 5 early region 1b 21,000-molecular-weight polypeptide leads to degradation of viral and host cell DNA.

Authors:  S Pilder; J Logan; T Shenk
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.